In this 2-year study, 787 patients with hypercholesterolemia received either atorvastatin 10
mg to 80 mg/day (623 patients) or lovastatin 20 mg to 80 mg/day (164 patients). Patients …

The efficacy of atorvastatin has been compared with lovastatin, pravastatin and simvastatin
in three large multicenter trials. Atorvastatin at its starting dose of 10 mg/day provided …

Upon completion of a one-year multicenter trial, 146 patients with severe
hypercholesterolemia and treated with atorvastatin 80 mg/day were entered into an open …

Data pooled from 21 atorvastatin clinical trials have been analyzed to establish the safety of
reducing low density lipoprotein cholesterol (LDL-C) levels below currently recommended …

Lowering of serum cholesterol levels by pharmacologic intervention with statins reduces the
incidence of cardiovascular events in subjects with and without atherosclerotic …

This double-blind study to evaluate long-term efficacy and safety of atorvastatin was
performed in 31 community-and university-based research centers in the USA to directly …

Plasma cholesterol and other lipoproteins play a significant role in the development of
atherosclerosis and subsequent coronary heart disease (CHD). This 1 year study was …

Background: High levels of total and LDL-cholesterol are associated with an increased risk
of atherosclerotic vascular disease. Lowering of serum cholesterol levels by pharmacologic …

This 1-year, double-blind, active-controlled, multicenter study compared the efficacy and
safety of atorvastatin to pravastatin and evaluated their ability to achieve target low-density …

The introduction of statins has drastically changed the treatment and prevention of
atherosclerotic vascular disease. By lowering lipid levels and reducing the risk of coronary …